Literature DB >> 11975522

A new biologically active malyngamide from a New Zealand collection of the sea hare Bursatella leachii.

David R Appleton1, Mary A Sewell, Michael V Berridge, Brent R Copp.   

Abstract

A new malyngamide, S (1), was isolated from a New Zealand collection of the sea hare Bursatella leachii and structurally characterized by spectroscopic methods and chemical degradation. Malyngamide S exhibited cytotoxicity and antiinflammatory properties.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11975522     DOI： 10.1021/np010511e

Source DB:  PubMed          Journal:  J Nat Prod        ISSN： 0163-3864            Impact factor:   4.050


  13 in total

Review 1.  Marine Mollusk-Derived Agents with Antiproliferative Activity as Promising Anticancer Agents to Overcome Chemotherapy Resistance.

Authors:  Maria Letizia Ciavatta; Florence Lefranc; Marianna Carbone; Ernesto Mollo; Margherita Gavagnin; Tania Betancourt; Ramesh Dasari; Alexander Kornienko; Robert Kiss
Journal:  Med Res Rev       Date:  2016-12-07       Impact factor: 12.944

Review 2.  Bioactive Compounds from Marine Heterobranchs.

Authors:  Conxita Avila; Carlos Angulo-Preckler
Journal:  Mar Drugs       Date:  2020-12-21       Impact factor: 5.118

Review 3.  High-value compounds from the molluscs of marine and estuarine ecosystems as prospective functional food ingredients: An overview.

Authors:  Kajal Chakraborty; Minju Joy
Journal:  Food Res Int       Date:  2020-08-31       Impact factor: 6.475

Review 4.  Marine natural product peptides with therapeutic potential: Chemistry, biosynthesis, and pharmacology.

Authors:  Vedanjali Gogineni; Mark T Hamann
Journal:  Biochim Biophys Acta Gen Subj       Date:  2017-08-24       Impact factor: 3.770

5.  Ketoreductase Domain Dysfunction Expands Chemodiversity: Malyngamide Biosynthesis in the Cyanobacterium Okeania hirsuta.

Authors:  Nathan A Moss; Tiago Leão; Michael R Rankin; Tyler M McCullough; Pingping Qu; Anton Korobeynikov; Janet L Smith; Lena Gerwick; William H Gerwick
Journal:  ACS Chem Biol       Date:  2018-12-03       Impact factor: 5.100

6.  Cytotoxic halogenated macrolides and modified peptides from the apratoxin-producing marine cyanobacterium Lyngbya bouillonii from Guam.

Authors:  Susan Matthew; Lilibeth A Salvador; Peter J Schupp; Valerie J Paul; Hendrik Luesch
Journal:  J Nat Prod       Date:  2010-09-24       Impact factor: 4.050

7.  Malyngamide 2, an oxidized lipopeptide with nitric oxide inhibiting activity from a Papua New Guinea marine cyanobacterium.

Authors:  Karla L Malloy; Francisco A Villa; Niclas Engene; Teatulohi Matainaho; Lena Gerwick; William H Gerwick
Journal:  J Nat Prod       Date:  2010-12-14       Impact factor: 4.050

8.  The structure elucidation of isomalyngamide K from the marine cyanobacterium Lyngbya majuscula by experimental and DFT computational methods.

Authors:  Bingnan Han; Uwe M Reinscheid; William H Gerwick; Harald Gross
Journal:  J Mol Struct       Date:  2011-03-15       Impact factor: 3.196

9.  Isolation and biological evaluation of 8-epi-malyngamide C from the Floridian marine cyanobacterium Lyngbya majuscula.

Authors:  Jason C Kwan; Max Teplitski; Sarath P Gunasekera; Valerie J Paul; Hendrik Luesch
Journal:  J Nat Prod       Date:  2010-03-26       Impact factor: 4.050

10.  Selective MyD88-dependent pathway inhibition by the cyanobacterial natural product malyngamide F acetate.

Authors:  Francisco A Villa; Kelly Lieske; Lena Gerwick
Journal:  Eur J Pharmacol       Date:  2009-12-16       Impact factor: 4.432
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.